Michael L. Stadius - Concepedia

Author

Michael L. Stadius

Stanford University

Also Known As

M L Stadius, M Stadius, M. Stadius, M.L. Stadius, Michael L Stadius, Michael L. Stadius, Michael Stadius

Publications

Citations

H-Index

Concepts

All Affiliations

Stanford University University of Washington University of Pittsburgh Stanford Medicine Cardiovascular Institute of the South

About

Michael L. Stadius is an author at Stanford University specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.3K
2	Public Health	9	9	750
3	Health Sciences	3	3	99
4	Engineering	2	2	227
5	Anatomy	1	1	23

Michael L. Stadius

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. John W. Kennedy, G. V. Martin, Kathryn Davis, Circulation ThrombosisCardiovascular DiseaseCoronary UnitInferior Myocardial InfarctionAnterior Myocardial Infarction	1988	245
Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. Tim A. Fischell, G. C. Derby, Tak-Ming Tse, Circulation Control SegmentHypertensionEndovascular TechniqueSurgeryBiomedical Engineering	1988	211
Intravascular ultrasound imaging of angiographically normal coronary arteries: An in vivo comparison with quantitative angiography Frederick G. St. Goar, Fausto J. Pinto, Edwin L. Alderman, Journal of the American College of Cardiology Medical UltrasoundNormal Coronary ArteriesEngineeringVascular ImageCardiovascular Disease	1991	184
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the bypass angioplasty revascularization investigation (BARI) Edwin L. Alderman, Kevin E. Kip, Patrick L. Whitlow, Journal of the American College of Cardiology Percutaneous Coronary InterventionVascular DiseaseFailed RevascularizationCardiovascular DiseaseVascular Surgery	2004	117
Determinants of normal coronary artery dimensions in humans. Michael L. Stadius, E L Alderman Circulation	1991	111
Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. Michael L. Stadius, Kathryn Davis, Charles Maynard, Circulation Heart FailureBaseline FactorsCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1986	106
Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy Peter B. Berger, James L. Velianou, Helen Vlachos, Journal of the American College of Cardiology Cardiac SurgeryPercutaneous Coronary InterventionMedical TherapyCardiovascular DiseaseOutcomes Research	2001	92
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial Emmanouil S. Brilakis, Robert Edson, Deepak L. Bhatt, The Lancet Endovascular TechniqueArterial ReconstructionsVascular SurgeryLumen-apposing Metal StentSaphenous Vein Grafts	2018	81
Coronary anatomy and left ventricular function in the first 12 hours of acute myocardial infarction: the Western Washington Randomized Intracoronary Streptokinase Trial. Michael L. Stadius, Charles Maynard, James K. Fritz, Circulation Heart FailureFirst 12Lad OcclusionCoronary Artery DiseaseAcute Myocardial Infarction	1985	70
Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function. G. V. Martin, Florence H. Sheehan, Michael L. Stadius, Circulation Cardiovascular PharmacologyRegional Systolic FunctionCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1988	66

Page 1